НовостиBenzingaHC Wainwright & Co. Maintains Buy on Opus Genetics, Raises Price Target to $14 HC Wainwright & Co. Maintains Buy on Opus Genetics, Raises Price Target to $14 Benzinga 2026.11.11 11:38 (GMT+0) Открыть на Benzinga Другие новости